Table 1.
Profiles | Vehicle (n) | THC (n) | % Change in profiles |
---|---|---|---|
Dendritic spines | |||
GluN1 positive | 202 | 296 | ↑ 46.5% |
GluN1 negative | 1768 | 2283 | ↑ 29.1% |
Column total | 1970 | 2579 | ↑ 30.9%* |
% GluN1 positive | 11% | 11% | 0% |
Dendritic shafts | |||
GluN1 positive | 1581 | 1427 | ↓ 9.7% |
GluN1 negative | 948 | 1053 | ↑ 11.1% |
Column total | 2529 | 2480 | ↓ 1.9% |
% GluN1 positive | 62.80% | 57.50% | ↓ 5% ** |
n = number of dendritic spines and shafts observed in 21,170 µm2 of PL-PFC tissue collected equally from ~70 microscopic images in two vibratome sections from adult mice receiving ∆9-THC (n = 5) or vehicle (n = 5) during adolescence. The receipt of ∆9-THC during adolescence resulted in a significant (*) increase in the density of dendritic spines as compared with mice receiving vehicle injections (χ2 (1) = 81.51, p < 0.0001) without changing the proportion of GluN1 immunolabeling between the two treatment groups (χ2 (1) = 1.72, p > 0.05). In contrast, there was no difference in the density of dendritic shafts between ∆9-THC-injected and vehicle-injected controls (χ2 (1) = 0.43, p > 0.05); however, there was a significant (**) decrease in the number of GluN1-positive dendritic shafts (χ2 (1) = 12.92, p, 0.0003)